|Articles|May 1, 2020
NeurologyLive Friday 5 — May 1, 2020
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 1, 2020.
Advertisement
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: David Langer, MD: Answering the Call for COVID-19
The chair of neurosurgery at Lenox Hill Hospital in Manhattan recently joined the ranks of health care providers who are caring for COVID-19 patients at the temporary hospital set up in the Javits Center.
2: AAN 2020: Ubrogepant More Effective in Mild Pain Migraine Attacks
Allergan’s oral CGRP antagonist showed a higher likelihood of freedom from pain and associated symptoms during mild headaches for patients with migraine compared to attacks of moderate to severe severity.
3: COViMS Registry Sheds Light on MS Patients With COVID-19
The Rosenthal—Trotter MS Chair in Neuroimmunology at Washington University School of Medicine in St. Louis details why the COViMS registry can serve as an important instrument for clinicians who treat patients with multiple sclerosis.
4: Peer Exchange: Overview of Spinal Muscular Atrophy
Crystal Proud, MD, leads a virtual panel discussion on spinal muscular atrophy, including the signs and symptoms that lead to a diagnosis.
5: Jennifer Frontera, MD: Neurologic Symptoms of COVID-19
The professor of neurology at NYU Langone detailed the neurologic symptoms that have been observed in patients with COVID-19.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
2
Expanding the Alzheimer Drug Development Pipeline
3
Shared Decision-Making and Ethics in Complex Neurology Clinical Research: Paul Ford, PhD
4
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
5